Pharmiweb ChannelsAll | PharmaCo | Clinical Research | R&D/BioTech | Sales/Mktg | Healthcare | Recruitment | Pharmacy | Medical Comms

Pharmiweb.com RSS Feed Pharmiweb.com RSS Feeds

Pharmiweb.com RSS Feed PharmiWeb Candidate Blog

Pharmiweb.com RSS Feed PharmiWeb Client Blog

Advertising

Press Release

LavoieHealthScience Selected as an MM&M Award Finalist for Orphan Product Category, Rett Syndrome Awareness

LaVoieHealthScience
Posted on: 26 Jul 17

LaVoieHealthScience (LHS), an award-winning integrated strategic communications agency focused on health and life science, was notified it has been selected as a MM&M award finalist for the agency’s Orphan Product initiative. The recognition is based on LHS’ disease awareness educational work on behalf of Newron Pharmaceuticals and in turn their work on the investigational drug, sarizotan for the treatment of apneas in patients with Rett syndrome.

LaVoieHealthScience is the U.S. PR & IR agency of record for Milan-based Newron Pharmaceuticals (SIX: NWRN), which has an approved Parkinson’s Disease drug and a pipeline of innovative candidates including sarizotan for Rett syndrome and evenamide for schizophrenia. LHS’ work on behalf of Newron’s Rett syndrome product candidate includes two videos (here & here) showing the challenges patients and families face when dealing with Rett. As a result of LHS’ initiative, the videos have received more than 5000 views, and Newron is now a well-established partner within the Rett syndrome community, including patient families and caregivers, as well as key opinion leaders.

“Being selected as a finalist for the MM&M Awards is a tremendous accomplishment for the LHS team and for patients and their caregivers which provides visibility and education on living with Rett syndrome,” said Donna L. LaVoie, President & CEO, LaVoieHealthScience. “Rett syndrome is such a challenging disease with limited treatment options and it is an honor to work with a Newron, alongside patient families and caregivers, the advocacy groups and leaders in Rett treatment and research.”

About LaVoieHealthScience

LaVoieHealthScience provides strategic communications, investor relations and public relations to build recognition and increase sales and value for health science innovations to improve humankind. The agency has received 28 awards over the past seven years in recognition of the work it has done for its health and science industry-leading clients. The agency ranks among the 2016 Inc. 5000 list of fastest growing private companies and among the Top 30 Independent Healthcare Firms as ranked by O’Dwyer’s PR.

View source version on businesswire.com: http://www.businesswire.com/news/home/20170725005116/en/

Business Wire
www.businesswire.com

Last updated on: 26/07/2017

Advertising
Share | | |
Site Map | Privacy & Security | Cookies | Terms and Conditions

PharmiWeb.com is Europe's leading industry-sponsored portal for the Pharmaceutical sector, providing the latest jobs, news, features and events listings.
The information provided on PharmiWeb.com is designed to support, not replace, the relationship that exists between a patient/site visitor and his/her physician.